| |
 |
| HFCWO
creates a gentle and rapid SQUEEZE and RELEASE action
around the chest from 5 to 20 times per second. |
| |
 |
| |
|
| The "mini-coughs" produced
with SmartVest® HFCWO
treatments |
 |
Shear mucus away
from the walls of the airways |
 |
Reduce the viscosity of
secretions |
 |
Propel mucus towards
the larger airways where it can be expectorated or suctioned
more easily |
|
|
How Does HFCWO
Work? |
| mEchanism of action |
| High Frequency
Chest Wall Oscillation (HFCWO, also known as High
Frequency Chest Compression (HFCC), has been an effective
form of airway clearance therapy for over 20 years.
HFCWO, administered by the patented SmartVest®,
creates a revolutionary SQUEEZE and RELEASE action
around the chest and torso from 5-20 times per second, delivering an effective and comfortable treatment.
The SmartVest® inflates
and delivers vigorous, yet comfortable, air pulses
to the body through a single-hose powered by a programmable
air pulse generator. The rapid squeeze and release
action simulates repetitive “mini-coughs,” which
have been reported in the medical literature to effectively |
 |
Shear
mucus away from the walls of a lung’s airways (1) |
 |
Reduce
the viscosity of the secretions (2) |
 |
Propel
the mucus toward the larger airways where it can
be expectorated or suctioned more easily (1,2) |
|
|
| Efficacy of HFCWO |
| HFCWO has been studied extensively and often compared to hospital quality Chest Physiotherapy
(CPT), a level of treatment that can rarely be maintained
in the home. In contrast to CPT, the quality of HFCWO
treatment does not change in home settings. CPT requires
a caregiver to clap and vibrate the chest wall to loosen
the secretions. This is combined with placing the patient
in head-down positions so gravity may assist
in draining secretions from the airway. Unlike CPT, HFCWO is technique-independent,
eliminating inconsistencies in clapping or cupping by
the caregiver. Also, because HFCWO employs a mechanism
different than that of CPT, it has advantages that make
it a superior choice for airway clearance therapy in the home. |
|
| Advantages of HFCWO |
 |
Greater
independence and adherence to prescribed treatment -
Most patients can self-administer the treatment, eliminating
dependence on a caregiver’s ability and availability,
thus preventing missed treatments due to lack of access
to treatment. The SmartVest® Airway
Clearance System is designed for travel and portability,
increasing independence. |
|
Position-independent - The SmartVest® Airway
Clearance System eliminates concerns associated
with manual Chest Physiotherapy (CPT) regarding patient
positioning in the Trendelenburg position and individual
technique variance. |
|
Greater
comfort and privacy - By eliminating the need
for head-down positioning, patients who cannot tolerate
positioning still have access to highly effective HFCWO
treatment. The compressions of the SmartVest® are
gentler than the clapping of CPT, and the SmartVest® material
is soft and breathable against the skin. The air pulse
generator is designed to avoid the appearance of medical
equipment, providing a higher level of privacy to the
patient. |
|
Time
saving - All areas of the lung are treated
simultaneously, and nebulized therapies can often be
incorporated into the treatment session, allowing the
patient to complete multiple therapies at the same
time. A typical treatment is administered twice a day
and can take from 15 to 30 minutes depending on physician
order. |
|
|
| |
|
| |
Electromed, Inc.’s SmartVest® Airway
Clearance System is designed to deliver High Frequency Chest
Wall Oscillation to promote airway clearance and improve bronchial
drainage. It is available only by prescription. |
| |
For
references, contact Electromed, Inc. at 800-462-1045. |
| |
1-
Chang HK, Weber ME, King M. Mucus transport by high-frequency
nonsymmetrical oscillatory airflow. J Appl Physiol 1988; 65(3):
1203-1209.
2- Majaesic C, Montgomery M, Jones R, King M. Reduction in sputum
viscosity using high frequency chest compressions compared to conventional
chest physiotherapy. Pediatr Pulmonol 1996; Suppl 13: A358. |
| |
|
| |
|
|